When we gathered for the Chemotherapy Foundation Symposium® (CFS®) last November, I was inspired by the dedication to patient care I observed. In a field as fast paced and complicated as oncology, staying current on the latest therapies and treatments directly impacts patient outcomes and quality of life.
Rapid advancements continue to occur across solid and liquid tumors, making one thing clear: Chemotherapy is no longer the only option for our patients. From lung cancer to melanoma, leukemia to breast cancer, targeted therapies and immunotherapies have fundamentally changed the way we treat cancer. Medical oncology is not alone in its radical shift; radiation and surgical oncology are quickly changing as well.
This message was particularly true at this year’s 2018 ASCO Annual Meeting, and one we look forward to expanding on in November.
Each year, CFS® brings together more than 1,000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for the most challenging clinical scenarios and cases we encounter every day. At this year’s 36th Annual CFS®, that tradition continues.
Continually learning, integrating what we’ve learned, and rising to meet new challenges are skills we’ve honed over years of practice. In our journey to ever improve patient care, we are not alone. The next generation of cancer care is here. Join us in New York, and we’ll meet it together!
Benjamin P. Levy, MD